Ixiaro
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Japanese encephalitis vaccine (inactivated, adsorbed)
- Made by
- Valneva Austria GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Ixiaro is indicated for active immunisation against Japanese encephalitis in adults, adolescents, children and infants aged two months and older. Ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Valneva Austria GmbH |
|---|---|
| Active substance | Japanese encephalitis vaccine (inactivated, adsorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BA02 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2009-03-31 |
| Last updated by the regulator | 2026-05-08 |
| EMA product number | EMEA/H/C/000963 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).